膀胱肿瘤实验研究的现状与展望  

Present situation and prospect of experimental study on bladder tumor

作　　者：胡嘏[1] 王少刚[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院泌尿外科,武汉430030

出　　处：《中华实验外科杂志》2016年第6期1440-1443,共4页Chinese Journal of Experimental Surgery

摘　　要：膀胱癌是最常见的恶性肿瘤，在全世界范围内每年可导致16000人死亡。到目前为止，对于膀胱癌的诊断和治疗仍不规范，缺乏精准、个体化治疗。本文以近年来基因组学、蛋白质组学及免疫学的发展为基础，围绕膀胱癌的分子分型、早期诊断、预后监测、化疗敏感性及免疫靶向治疗等方面展开深入探讨。Bladder carcinoma is a common malignancy that causes approximately 160 000 deaths per year worldwide. So far, no standard, precise and individualized method have been used for diagnosis and treatment of the disease. In this study, we discuss the molecular characterization, early diagnosis, prognosis monitoring, chemotherapy sensitivity and immune targeted therapy of bladder carcinoma ,which based on de- velopment of genomics, proteomics and immunology in recent years.

关 键 词：膀胱癌 分子分型 早期诊断 预后监测 免疫靶 向治疗 

分 类 号：R737.14[医药卫生—肿瘤]